Luke Coyle

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

Robert A. Brodsky, Neal S. Young, Elisabetta Antonioli et al. · Blood · 2007 · 653 citations

Medicine, Hematology, Pharmacology +11

Consolidation Therapy With Low-Dose Thalidomide and Prednisolone Prolongs the Survival of Multiple Myeloma Patients Undergoing a Single Autologous Stem-Cell Transplantation Procedure

Andrew Spencer, H. Miles Prince, Andrew W. Roberts et al. · Journal of Clinical Oncology · 2009 · 333 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Refining the Human iPSC-Cardiomyocyte Arrhythmic Risk Assessment Model

Liang Guo, Luke Coyle, Rory Abrams et al. · Toxicological Sciences · 2013 · 159 citations · Full text

Medicine, Cardiology, Pharmacology +14

Minimal Residual Disease Tests Provide an Independent Predictor of Clinical Outcome in Adult Acute Lymphoblastic Leukemia

Forida Y. Mortuza, Mary Papaioannou, Ilidia M. Moreira et al. · Journal of Clinical Oncology · 2002 · 116 citations

Medicine, Hematology, Oncology +17

Recombinant activated factor VII for the treatment of life-threatening haemorrhage

John W. Eikelboom, Robert Bird, David Blythe et al. · Blood Coagulation & Fibrinolysis · 2003 · 90 citations

Medicine, Hematology, Surgery +7